| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |